E-Paper
Sign In
iPhone | iPad
Android
Mon, Dec 23, 2024 | Jumada al-Aakhirah 22, 1446 | DXB
0°C
Covid-19: 2 dead, 423 fresh cases reported in India
The total number of active cases in the country has risen to 3,420
Health officials perform Covid-19 test on a man at the Municipal Corporation Hospital in Thane on Friday. Photo: PTI
A multifold spurt in fresh Covid cases was noted in India over the past 24 hours, with Kerala contributing the major chunk of those.
A total of 423 cases were reported and of which 266 were from Kerala and 70 from neighbouring Karnataka, Union health ministry data showed.
Two deaths were reported in Kerala.
Stay up to date with the latest news. Follow KT on WhatsApp Channels.
The total number of active cases of Covid-19 in the country was recorded at 3,420.
The World Health Organisation (WHO) recently classified JN.1 as a variant of interest, distinct from its parent lineage BA.2.86. However, the global health body emphasised that the overall risk posed by JN.1 remains low based on current evidence.
The number of new Covid cases increased by 52 per cent during the past four-odd weeks, the WHO said, with over 850 000 new cases reported during the period.
The number of new deaths decreased by 8 per cent as compared to the previous 28-day period, with over 3,000 new fatalities reported, WHO said in its latest press release.
Over 772 million confirmed cases
As of December 17, over 772 million confirmed cases and nearly seven million deaths have been reported globally since the onset of Covid-19, the WHO noted.
Further, the WHO said over 118,000 new Covid-19 hospitalisations and over 1600 new intensive care unit (ICU) admissions have been recorded, with an overall increase of 23 per cent and 51 per cent, respectively, globally.
Due to its rapidly increasing spread, WHO is classifying the variant JN.1 as a separate variant of interest (VOI) from the parent lineage BA.2.86. It was previously classified as VOI as part of BA.2.86 sublineages.
A medic puts up a notice at a Covid-19 testing centre of the district hospital in Chikkamagaluru on Saturday. Photo: PTI
Based on the available evidence, the additional global public health risk posed by JN.1 is currently evaluated as low. Despite this, with the onset of winter in the Northern Hemisphere, JN.1 could increase the burden of respiratory infections in many countries.
The WHO had earlier said it was continuously monitoring the evidence and would update the JN.1 risk evaluation as needed.
Vaccines
Current vaccines continue to protect against severe disease and death from JN.1 and other circulating variants of SARS-CoV-2, the virus that causes Covid-19, it noted.
COVID-19 is not the only respiratory disease circulating. Influenza, RSV, and common childhood pneumonia are also on the rise.
The WHO advises people to take measures to prevent infections and severe disease using all available tools. These include wearing a mask when in crowded, enclosed, or poorly ventilated areas, keeping a safe distance from others, practicing respiratory etiquette (covering coughs and sneezes), cleaning hands regularly, and getting tested if one has any symptoms or if you might have been exposed to someone with Covid-19 or influenza.
ALSO READ:
Sign Up For Breaking News Alerts
Be in the know. Get the latest breaking news delivered straight to your inbox.
